REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmasan S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pharmasan S.A.S. Profile Updated: April 08, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Pharmasan S.A.S. is an enterprise in Colombia, with the main office in Bucaramanga. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on October 30, 2008. There are currently 489 (2026) people employed by Pharmasan S.A.S.. The company’s latest financial report indicates a net sales revenue increase of 159.71% in 2025. Its’ total assets recorded a growth of 7.58%. In 2025, Pharmasan S.A.S.’s net profit margin increased by 0.23%.

Headquarters
Calle 32 # 30 - 34 Barrio Mejoras Publicas
Bucaramanga; Santander;

Contact Details: Purchase the Pharmasan S.A.S. report to view the information.

Website: http://www.coprin.com.co

Basic Information
Total Employees:
Purchase the Pharmasan S.A.S. report to view the information.
Registered Capital:
Purchase the Pharmasan S.A.S. report to view the information.
Financial Auditors:
Purchase the Pharmasan S.A.S. report to view the information.
Incorporation Date:
October 30, 2008
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Pharmasan S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
159.71%
Total Operating Revenue
159.71%
Net Profit/Loss for the Period
241.38%
Total Assets
7.58%
Total Equity
12.22%
Net Profit Margin
0.23%
Return on Equity (ROE)
6.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?